Sign in

CIK 0001540159

  • Non-accelerated filer
  • Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 905-475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Option exercise Director acquired 4,262 shares (option exercise)
  2. 4 Option exercise President acquired 914 shares (option exercise)
  3. 4 Option exercise Chief Financial Officer acquired 609 shares (option exercise)
  4. 4 Option exercise Director acquired 1,218 shares (option exercise)
  5. 4 Option exercise Chief Executive Officer acquired 4,628 shares (option exercise)
  6. 4 Option exercise Director acquired 609 shares (option exercise)
  7. 4 Option exercise Director acquired 70,314 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Other acquisition Chief Executive Officer acquired 371,727 shares (other)
  18. 4 Open-market buy President bought 2,500 shares at an average $3.00 ($7,499)
  19. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $2.98 ($8,939)
  20. 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.87 ($9,373)

Page 8 of 14 · 261 filings